The Ministry of Economy in Abu Dhabi has been granted a patent for the development of an innovative and promising treatment for COVID-19 infections using stem cells. The cutting edge treatment was developed by a team of doctors and researchers at the Abu Dhabi Stem Cell Center, ADSCC, and involves extracting stem cells from the patient’s own blood and reintroducing them after activating them. The patent was granted for the innovative method in which the stem cells are collected.
In trials, the treatment was administered in the UAE to 73 COVID-19 patients. All have been successfully treated and cured of the virus by inhaling the treatment into their lungs after it was nebulized into a fine mist. According to early information from Abu Dhabi, the treatment helps regenerate lung cells and modulate the immune response, thus preventing the COVID-19 infection cause further damage to healthy cells.
The treatment has successfully undergone the first phase of clinical trials. None of the test-case patients reported immediate adverse effects. Meanwhile, further trials to demonstrate the efficacy of the treatment are ongoing and expected to be completed in a couple of weeks.
The new treatment has been administered to patients alongside the conventional medical interventions and will continue to be applied as an adjunct to established treatment protocols rather than as a replacement. Non-pharmacological precautions to prevent the spread of COVID-19 such as staying at home, social distancing and infection prevention and control measures remain necessary to reduce the burden of the disease on the healthcare system.